Cargando…
Characterization of (18)F-PM-PBB3 ((18)F-APN-1607) Uptake in the rTg4510 Mouse Model of Tauopathy
Misfolding, aggregation, and cerebral accumulation of tau deposits are hallmark features of Alzheimer’s disease. Positron emission tomography study of tau can facilitate the development of anti-tau treatment. Here, we investigated a novel tau tracer (18)F-PM-PBB3 ((18)F-APN-1607) in a mouse model of...
Autores principales: | Weng, Chi-Chang, Hsiao, Ing-Tsung, Yang, Qing-Fang, Yao, Cheng-Hsiang, Tai, Chin-Yin, Wu, Meng-Fang, Yen, Tzu-Chen, Jang, Ming-Kuei, Lin, Kun-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181044/ https://www.ncbi.nlm.nih.gov/pubmed/32290239 http://dx.doi.org/10.3390/molecules25071750 |
Ejemplares similares
-
Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
por: Lin, Huan-Chun, et al.
Publicado: (2023) -
Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy
por: Blackmore, Thomas, et al.
Publicado: (2017) -
Altered Brain Metabolome Is Associated with Memory Impairment in the rTg4510 Mouse Model of Tauopathy
por: Tondo, Mireia, et al.
Publicado: (2020) -
Tau Causes Synapse Loss without Disrupting Calcium Homeostasis in the rTg4510 Model of Tauopathy
por: Kopeikina, Katherine J., et al.
Publicado: (2013) -
Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
por: Wang, Xiaohai, et al.
Publicado: (2018)